- Home
- OCEA vs NXTT Comparison
OCEA vs NXTT Comparison
Compare OCEA & NXTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEA
- NXTT
- Stock Information
- Founded
- OCEA 2019
- NXTT 2019
- Country
- OCEA United States
- NXTT China
- Employees
- OCEA N/A
- NXTT N/A
- Industry
- OCEA Biotechnology: Pharmaceutical Preparations
- NXTT
- Sector
- OCEA Health Care
- NXTT
- Exchange
- OCEA Nasdaq
- NXTT NYSE
- Market Cap
- OCEA 20.5M
- NXTT 19.5M
- IPO Year
- OCEA N/A
- NXTT N/A
- Fundamental
- Price
- OCEA $0.13
- NXTT $1.31
- Analyst Decision
- OCEA
- NXTT
- Analyst Count
- OCEA 0
- NXTT 0
- Target Price
- OCEA N/A
- NXTT N/A
- AVG Volume (30 Days)
- OCEA 88.9M
- NXTT 334.1K
- Earning Date
- OCEA 01-13-2025
- NXTT 04-15-2025
- Dividend Yield
- OCEA N/A
- NXTT N/A
- EPS Growth
- OCEA N/A
- NXTT N/A
- EPS
- OCEA N/A
- NXTT 3.59
- Revenue
- OCEA N/A
- NXTT $1,133,308.00
- Revenue This Year
- OCEA N/A
- NXTT N/A
- Revenue Next Year
- OCEA N/A
- NXTT N/A
- P/E Ratio
- OCEA N/A
- NXTT $0.37
- Revenue Growth
- OCEA N/A
- NXTT N/A
- 52 Week Low
- OCEA $0.11
- NXTT $0.94
- 52 Week High
- OCEA $7.79
- NXTT $6.66
- Technical
- Relative Strength Index (RSI)
- OCEA 28.02
- NXTT 41.83
- Support Level
- OCEA $0.12
- NXTT $1.03
- Resistance Level
- OCEA $0.16
- NXTT $1.23
- Average True Range (ATR)
- OCEA 0.04
- NXTT 0.15
- MACD
- OCEA 0.01
- NXTT 0.03
- Stochastic Oscillator
- OCEA 8.66
- NXTT 66.67
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About NXTT NEXT TECHNOLOGY HOLDING INC
Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.